Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP626151.RARlF3-lgs5CVcZnhyg2u6J4T9J7KUMIWz21rEwlAo0sI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP626151.RARlF3-lgs5CVcZnhyg2u6J4T9J7KUMIWz21rEwlAo0sI130_assertion type Assertion NP626151.RARlF3-lgs5CVcZnhyg2u6J4T9J7KUMIWz21rEwlAo0sI130_head.
- NP626151.RARlF3-lgs5CVcZnhyg2u6J4T9J7KUMIWz21rEwlAo0sI130_assertion description "[The higher expression levels of Bmi-1 correlated with well-established markers of poor clinical outcome in breast cancer such as positive p53 immunostaining and negative progesterone receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP626151.RARlF3-lgs5CVcZnhyg2u6J4T9J7KUMIWz21rEwlAo0sI130_provenance.
- NP626151.RARlF3-lgs5CVcZnhyg2u6J4T9J7KUMIWz21rEwlAo0sI130_assertion evidence source_evidence_literature NP626151.RARlF3-lgs5CVcZnhyg2u6J4T9J7KUMIWz21rEwlAo0sI130_provenance.
- NP626151.RARlF3-lgs5CVcZnhyg2u6J4T9J7KUMIWz21rEwlAo0sI130_assertion SIO_000772 17711569 NP626151.RARlF3-lgs5CVcZnhyg2u6J4T9J7KUMIWz21rEwlAo0sI130_provenance.
- NP626151.RARlF3-lgs5CVcZnhyg2u6J4T9J7KUMIWz21rEwlAo0sI130_assertion wasDerivedFrom befree-2016 NP626151.RARlF3-lgs5CVcZnhyg2u6J4T9J7KUMIWz21rEwlAo0sI130_provenance.
- NP626151.RARlF3-lgs5CVcZnhyg2u6J4T9J7KUMIWz21rEwlAo0sI130_assertion wasGeneratedBy ECO_0000203 NP626151.RARlF3-lgs5CVcZnhyg2u6J4T9J7KUMIWz21rEwlAo0sI130_provenance.